Location: New York, NY
CIK: 0002052213 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $352M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 1,170,740 | $45.06M | 12.8% | $28.11 | +32.9% | COM | 19240Q201 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,855,000 | $43.33M | 12.3% | $17.45 | +19.0% | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 865,000 | $27.44M | 7.8% | $26.34 | -3.5% | COM NEW | 15117B202 |
| CTMX | CYTOMX THERAPEUTICS INC. | 4,550,000 | $21.39M | 6.1% | $5.01 | +4.4% | COM | 23284F105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,021,300 | $20.56M | 5.8% | $13.73 | +12.8% | COM | 483497103 |
| CGON | CG ONCOLOGY INC | 291,800 | $19.75M | 5.6% | $41.38 | +26.7% | COM | 156944100 |
| VERA | VERA THERAPEUTICS INC | 482,500 | $19.41M | 5.5% | $35.52 | +26.6% | CL A | 92337R101 |
| PCVX | VAXCYTE INC | 316,500 | $18.39M | 5.2% | $45.36 | +16.3% | COM | 92243G108 |
| PHVS | PHARVARIS N V | 475,750 | $13.44M | 3.8% | $24.09 | +11.0% | COM | N69605108 |
| TYRA | TYRA BIOSCIENCES INC | 350,000 | $13.4M | 3.8% | $18.37 | +64.7% | COM | 90240B106 |
| BEAM | BEAM THERAPEUTICS INC | 476,338 | $11.35M | 3.2% | $25.51 | +14.4% | COM | 07373V105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 534,931 | $10.46M | 3.0% | $27.43 | +12.4% | COM | 92790C104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,000,000 | $9.52M | 2.7% | $7.23 | -3.2% | COM | 09058V103 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 15,000 | $8.895M | 2.5% | $469.63 | +2.3% | COM | 91307C102 |
| CGEM | CULLINAN THERAPEUTICS INC | 530,000 | $7.531M | 2.1% | $10.24 | +16.8% | COM | 230031106 |
| NRIX | NURIX THERAPEUTICS INC | 460,000 | $7.13M | 2.0% | $14.37 | +20.7% | COM | 67080M103 |
| MBX | MBX BIOSCIENCES INC | 211,000 | $6.298M | 1.8% | $24.26 | +51.8% | COM | 55287L101 |
| KRYS | KRYSTAL BIOTECH INC | 22,000 | $5.683M | 1.6% | $210.47 | +29.4% | COM | 501147102 |
| DBVT | DBV TECHNOLOGIES S A | 265,000 | $5.536M | 1.6% | $20.89 | — | SPONSORED ADS | 23306J309 |
| RLAY | RELAY THERAPEUTICS INC | 536,946 | $5.343M | 1.5% | $7.14 | +16.3% | COM | 75943R102 |
| TVTX | TRAVERE THERAPEUTICS INC | 177,600 | $5.276M | 1.5% | $31.95 | -2.9% | COM | 89422G107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 38,000 | $4.005M | 1.1% | $81.85 | +1.8% | COM | 74366E102 |
| URGN | UROGEN PHARMA LTD | 220,000 | $3.956M | 1.1% | $21.23 | -1.8% | COM | M96088105 |
| ALMS | ALUMIS INC | 130,000 | $2.864M | 0.8% | $24.33 | 0.0% | COM | 022307102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 47,000 | $2.655M | 0.8% | $54.44 | +7.9% | COM | 09061G101 |
| DSGN | DESIGN THERAPEUTICS INC | 207,900 | $2.212M | 0.6% | $7.83 | +27.5% | COM | 25056L103 |
| APLS | APELLIS PHARMACEUTICALS INC | 50,000 | $2.011M | 0.6% | $23.46 | -3.3% | COM | 03753U106 |
| ALEC | ALECTOR INC | 900,000 | $1.935M | 0.5% | $1.77 | +7.5% | COM | 014442107 |
| IMCR | IMMUNOCORE HLDGS PLC | 58,248 | $1.756M | 0.5% | $34.71 | — | ADS | 45258D105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 112,000 | $1.557M | 0.4% | $13.58 | +3.0% | COM | 03237H101 |
| ENGN | ENGENE HOLDINGS INC | 210,000 | $1.43M | 0.4% | $8.01 | +20.6% | COM | 29286M105 |
| WVE | WAVE LIFE SCIENCES LTD | 177,846 | $1.289M | 0.4% | $10.16 | +35.3% | SHS | Y95308105 |
| SUPN | SUPERNUS PHARMACEUTICALS | 20,000 | $1.034M | 0.3% | $48.62 | +3.9% | COM | 868459108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 10,000 | $315K | 0.1% | $20.07 | +40.4% | COM | 28036F105 |